Author

Julia Lezzoni

Observed name: Julia C. lezzoni

Institutions: Mayo Clinic, Medical University of South Carolina, Oregon Health & Science University, The University of Texas at San Antonio Health Science Center, Baylor University Medical Center, University of Virginia

Observed institutions: Mayo Clinic, Medical University of South Carolina, Oregon Health & Science University, The University of Texas at San Antonio Health Science Center, Baylor University Medical Center, University of Virginia Medical Center, University of Virginia

OpenAlex ID: A5026126294

Inhibin Is Not an Immunohistochemical Marker for Hepatocellular Carcinoma: An Example of the Potential Pitfall in Diagnostic Immunohistochemistry Caused by Endogenous Biotin

1999 · Julia C. lezzoni, Stacey E. Mills, et al. · American Journal of Clinical Pathology · 42

Interobserver Agreement in Hepatitis C Grading and Staging and in the Banff Grading Schema for Acute Cellular Rejection: The “Hepatitis C 3” Multi-Institutional Trial Experience

2006 · George J. Netto, David L. Watkins, et al. · Archives of Pathology & Laboratory Medicine · 26

Works count: 2

Citation count: 68

H-index: 2

I10-index: 2